News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Bruck Claudine
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/20/2023 |
4
| Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.
Txns:
| Granted 5,967 options to buy
@ $13.17, valued at
$78.6k
|
|
01/05/2022 |
4
| Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.
Txns:
| Granted 8,000 options to buy
@ $19.78, valued at
$158.2k
|
|
10/13/2021 |
4
| Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.
Txns:
| Bought 181 shares
@ $27.66, valued at
$5k
|
|
07/09/2021 |
4
| Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.
Txns:
| Granted 4,000 options to buy
@ $102.85, valued at
$411.4k
|
|
07/07/2021 |
4
| Bruck Claudine (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.
Txns:
| Granted 3,969 shares
@ $0 |
|
01/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2020 |
4
| Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.
Txns:
| Bought 800 shares
@ $6, valued at
$4.8k
Converted 3,969 shares
@ $0 Converted 1,117 shares
@ $4.8, valued at
$5.4k
Converted 5,556 preferred shares
@ $0 Converted 1,117 convertible notes
@ $4.8, valued at
$5.4k
|
|
01/29/2020 |
3
| Bruck Claudine (Director) has filed a Form 3 on Annovis Bio, Inc. |
05/15/2019 |
4
| Bruck Claudine (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.
Txns:
| Bought 2,550 shares
@ $1.904, valued at
$4.9k
|
|
02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/16/2018 |
4
| Bruck Claudine (Director) has filed a Form 4 on NAVIDEA BIOPHARMACEUTICALS, INC.
Txns:
| Granted 50,000 shares
@ $0.001, valued at
$50 Granted 50,000 options
@ $0.75, valued at
$37.5k
|
|
03/14/2018 |
3
| Bruck Claudine (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
|
|